Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.93
+0.10001.46%
Post-market: 6.90-0.0300-0.43%19:50 EDT
Volume:6.04M
Turnover:42.23M
Market Cap:2.43B
PE:-15.80
High:7.09
Open:6.98
Low:6.88
Close:6.83
52wk High:9.75
52wk Low:2.76
Shares:351.12M
Float Shares:264.00M
Volume Ratio:0.72
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:9.58
PE(LYR):-11.55

Loading ...

Nuvation Bio Prices Upsized USD 287.5 Million Convertible Senior Notes After Full Greenshoe Exercise

Reuters
·
Jul 07

Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering

THOMSON REUTERS
·
Jul 07

Nuvation Bio Plans Offering of $200 Million Convertible Senior Notes Due 2032

Reuters
·
Jul 01

Nuvation Bio Faces More Predictable Growth Supported by Ibtrozi Frontline Adoption, Wedbush Says

MT Newswires Live
·
Jul 01

Nuvation Bio's Taletrectinib Enters UK Regulatory Review

MT Newswires Live
·
Jun 29

Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced Ros1-positive Non-small Cell Lung Cancer Validated in the United Kingdom

THOMSON REUTERS
·
Jun 29

Nuvation Bio (NUVB) Completes $250 Million Note Offering, Is The Stock Fully Priced?

Simply Wall St.
·
Jun 28

Exchange-Traded Funds, Equity Futures Decline Pre-Bell Friday as Investors Shift Focus From Middle East to Technology Stocks

MT Newswires Live
·
Jun 26

Nuvation Bio prices upsized offering of $250M of convertible senior notes

TIPRANKS
·
Jun 26

Nuvation Bio Announces Pricing of Upsized Offering of $250.0 Million of Convertible Senior Notes

THOMSON REUTERS
·
Jun 26

Nuvation Bio Slides on Planned $200 Mln Convertible Offering

Reuters
·
Jun 25

Nuvation Bio falls -10.1%

TIPRANKS
·
Jun 25

Nuvation Bio Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Jun 25

Nuvation Bio - to Offer $200 Mln Convertible Senior Notes Due 2032

THOMSON REUTERS
·
Jun 25

Nuvation Bio - Proceeds to Fund Capped Calls, Repay Senior Loan, and General Corporate Purposes

THOMSON REUTERS
·
Jun 25

Nuvation Bio CFO Philippe Sauvage Disposes of 47,668 Common Shares Worth $286,650.16

Reuters
·
Jun 25

Nuvation Bio posts corporate deck spotlighting IBTROZI launch, oncology pipeline programs

Reuters
·
Jun 17

Nuvation Bio director Robert Mashal reports purchase of 25,000 shares for $118,250

Reuters
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Teva Pharmaceutical (TEVA) and Nuvation Bio (NUVB)

TIPRANKS
·
Jun 10

Will TRUST-II Quality-of-Life Data and Global Milestones Change Nuvation Bio's (NUVB) Narrative?

Simply Wall St.
·
Jun 07